Clinical Trials Directory

Trials / Completed

CompletedNCT04680663

Predictor of Postoperative Complications After Lengthy Noncardiac Surgery

Peripheral Perfusion Index Versus Serum Lactate Levels as Predictor of Postoperative Complications and Prolonged ICU Stay After Lengthy Surgical Procedures: a Prospective Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
235 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Many patients undergoing long time surgery will manifest increased level of blood lactate. Hyperlactacidemia can cause disturbance of internal environment, then leading to increased complications and longer ICU stay, even death. For postoperative patients, we must ensure adequate perfusion in order to minimize the length of hyperglycemia and improve patients' outcomes. With regard to lactate, it provides information about prefusion, but not timely enough for its delay on reflecting hypoperfusion. And it's not real-time and non-invasive. Peripheral perfusion index (PPI) is an indicator reflecting hypoperfusion in critical patients. It is measured using pulse co-oximetry technology which is characterized by being real-time and noninvasive. PPI is defined as "the ratio of pulsatile blood flow to the non-pulsatile blood flow", mirroring the strength of blood flow and quality of perfusion at sensor site, reflecting perfusion state of the body part . In contrast to lactate value, it's real-time and easy to monitor.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPeripheral Perfusion indexPeripheral Perfusion index is the ratio between pulsatile blood flow to non pulsatile blood flow or static blood in the peripheral tissue
DIAGNOSTIC_TESTserum lactate levelBlood lactate (product of metabolism) level is maintained by a cycle of continuous production and metabolism allowing it to be kept within normal values

Timeline

Start date
2021-03-15
Primary completion
2024-05-12
Completion
2024-06-10
First posted
2020-12-23
Last updated
2025-01-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04680663. Inclusion in this directory is not an endorsement.